Neuroleptic malignant syndrome associated with risperidone in a male with early-onset schizophrenia.
Mané
A
A
Baeza
I
I
Morer
A
A
Lázaro
M L
ML
Bernardo
M
M
D000284:Administration, Oral; D000293:Adolescent; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D003024:Clozapine / Q000008:administration & dosage / Q000009:adverse effects; D003131:Combined Modality Therapy; D004565:Electroconvulsive Therapy; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D008728:Methotrimeprazine / Q000008:administration & dosage / Q000009:adverse effects; D009459:Neuroleptic Malignant Syndrome / Q000175:diagnosis* / Q000628:therapy; D012008:Recurrence; D018967:Risperidone / Q000008:administration & dosage / Q000009:adverse effects*; D012559:Schizophrenia / Q000188:drug therapy*
D014150:Antipsychotic Agents; D008728:Methotrimeprazine; D003024:Clozapine; D018967:Risperidone